In this review:
ABSORB II: Absorb BVS, Xience give similar outcomes at 2 years
ABSORB III: novel bioresorbable scaffold as good as standard-of-care DES
BIOSOLVE-II: novel absorbable scaffold safe, effective
LEADERS FREE: DES better than BMS in high-risk PCI
MASTER: positive results seen for bioresorbable-polymer DES in STEMI
PLATFORM: FFRCT reduces costs compared with invasive coronary angiography
Manual thrombectomy does not improve outcomes in high-risk STEMI
TUXEDO: everolimus-eluting stent superior to paclitaxel-eluting stent in diabetes
SORT-OUT VI: 3-year data similar with biolimus- and zotarolimus-eluting stents
RESPECT confirms long-term safety, efficacy of PFO closure for recurrent stroke
Please login below to download this issue (PDF)